Yahoo Web Search

Search results

  1. Heather Bresch (née Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan , becoming the first woman to run a Fortune 500 pharmaceutical company. [3]

    • 4
    • Heather Kirby
  2. Mar 17, 2022 · Heather Bresch, the former CEO of Mylan and the daughter of Sen. Joe Manchin, D-W.Va., was accused of inflating the price of EpiPens and facing legal consequences. The settlement of a federal antitrust case means she will avoid trial and keep her job as a West Virginia University president.

  3. Jul 29, 2019 · Bresch has led Mylan since 2012, overseeing its growth from a generics company to a global pharmaceutical giant. She will step down in mid-2020, after the deal with Pfizer's Upjohn business, following years of controversies and investigations.

    • Eric Sagonowsky
  4. Sep 7, 2021 · Heather Bresch, the former president and CEO of Mylan, worked with Pfizer to corner the market and keep prices of the EpiPen high, according to new documents released as part of an ongoing lawsuit. The documents also show Bresch approving a scheme to force customers to purchase two EpiPens at once, regardless of medical need.

    • Ryan Grim
    • Heather Bresch1
    • Heather Bresch2
    • Heather Bresch3
    • Heather Bresch4
    • Heather Bresch5
  5. Heather Bresch is the chief executive officer of Mylan, a global generics and specialty pharmaceutical company. She has advocated for access to medicine, especially for HIV/AIDS, biologics and food allergies, and has led several acquisitions and policy changes at Mylan.

  6. Aug 30, 2023 · Heather Manchin Bresch, 54, became the first woman to run a Fortune 500 pharmaceutical company when she took over the Netherlands-based Mylan in 2012. Bresch and her company were criticized for ...

  7. People also ask

  8. www.forbes.com › profile › heather-breschHeather Bresch - Forbes

    Heather Bresch is the CEO of Mylan, a generic drug maker that has grown rapidly under her leadership. Read her profile, Forbes lists ranking, and related articles on health care, business, and innovation.

  1. People also search for